Consistent with mRNA data, elevated protein level of Nrf2 and reduced protein level of SLC40A1 were also found in two cisplatin–resistant ovarian cancer cells (Figure 1B, 1C). This evidence concerns the gene NFE2L2 and ovarian carcinoma.